CRISPR Therapeutics AG (CRSP) IPO Opens Up 7%

October 19, 2016 10:37 AM EDT
Get Alerts CRSP Hot Sheet
Trade CRSP Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Today's IPO for CRISPR Therapeutics AG (Nasdaq: CRSP) opened for trading at $15 after pricing its initial public offering of 4,000,000 common shares at a public offering price of $14.00 per share.

Citigroup, Piper Jaffray and Barclays are acting as joint book-running managers for the offering. Guggenheim Securities is acting as co-manager.

CRISPR Therapeutics is a leading gene-editing company focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

IPOs

Related Entities

Piper Jaffray, Citi, Barclays, IPO, Guggenheim

Add Your Comment